Results

Total Results: 1,052 records

Showing results for "achieved".

  1. effectivehealthcare.ahrq.gov/products/machine-learning/research
    September 07, 2012 - When attempting to maximize sensitivity, GLMnet achieved high sensitivities (0.99 for AAP and 1.0 for … The system achieved higher sensitivity in evaluating efficacy/effectiveness articles than in evaluating
  2. effectivehealthcare.ahrq.gov/products/urinary-incontinence-treatment/research
    April 09, 2012 - Continence was achieved in one woman with urgency UI for every eight women treated with fesoterodine … Continence was achieved in one woman for every three treated with pelvic floor muscle training (NNT=3
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - After 3 months 88% achieved ACR Pedi 30. After 12 months, 76% did. … By week 96, ACR Pedi 30, 50, and 70 responses were achieved by 98%, 93%, and 93% of 25 patients. … Of these 11, 91% showed ACRpedi50 and 73% showed ACRpedi70 response. 36% achieved inactive disease … Normalized body temperature and absence of evanescent rashes were achieved after a median of 4 days … After 12 months, 9 patients in Arm 1 and 3 in Arm 2 achieved clinical remission (p=0.0534) Tynjala
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - After 3 months 88% achieved ACR Pedi 30. After 12 months, 76% did. … By week 96, ACR Pedi 30, 50, and 70 responses were achieved by 98%, 93%, and 93% of 25 patients. … Of these 11, 91% showed ACRpedi50 and 73% showed ACRpedi70 response. 36% achieved inactive disease … Normalized body temperature and absence of evanescent rashes were achieved after a median of 4 days … After 12 months, 9 patients in Arm 1 and 3 in Arm 2 achieved clinical remission (p=0.0534) Tynjala
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/insulin-blood-sugar_research.pdf
    August 01, 2015 - ES-3 Phase 4 Research questions were developed based on feedback from stakeholders that achieved … Phase 3 Consensus was achieved during phase 2, negating the need to build consensus in phase 3. … Phase 3 Consensus was also achieved during phase 2 for the research priorities on insulin-requiring … Research questions were developed based on feedback from stakeholders that achieved consensus during … Phase 3 Consensus was also achieved for insulin-requiring type 2 diabetes during phase 2.
  6. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/updating-treatments-fecal-incontinence-viii
    March 31, 2021 - There have been other bulking agents have not been studied to this degree or achieved approval by FDA
  7. effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1412.pdf
    December 22, 2014 - Patients with genotype 3 infection treated with daclatasvir/sofosbuvir for 24 weeks achieved SVR12 … Patients with HCV genotype 1 infection and Child-Pugh class A cirrhosis achieved SVR rates of more … These rates were superior to an estimated historical control rate achieved with a telaprevir-based … Patients treated with ledipasvir/sofosbuvir for 24 weeks with or without RBV achieved an SVR of 99% … Patients treated for 12 weeks achieved an SVR12 of 92%.
  8. - (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease-future_research.pdf
    July 01, 2016 - Consensus was not achieved for other medication comparisons (Table C). … research; however, there is some ambiguity regarding the best monotherapy comparison as thiopurine achieved … * Severe disease 1 * Mild disease 1 * Non-Whites 0 * Elderly 0 * Other 3 * * Consensus achieved … Among medication comparisons for induction of remission, only one medication comparison achieved consensus … Consensus was not achieved on a third medication comparison.
  9. effectivehealthcare.ahrq.gov/products/publication-bias/research
    September 16, 2011 - Meaningful, albeit incomplete, reduction in the bias of estimated metaregression model parameters was achieved
  10. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - significantly more patients treated with lesinurad in combination with a xanthine oxidase inhibitor achieved … In the CLEAR1 trial, patients given lesinurad 200 mg or 400 mg, and 54% and 59%, respectively, achieved … trial, patients were also treated with lesinurad 200 mg or 400 mg, and 55% and 67%, respectively, achieved … Data reported by the manufacturer showed that more patients treated with lesinurad and febuxostat achieved … Data from the manufacturer showed a significantly higher proportion of patients receiving lesinurad achieved
  11. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/update-treatments-fecal-incontinence
    March 15, 2021 - Moreover, other bulking agents have not been studied to this degree or achieved approval by FDA for this
  12. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/updating-treatments-fecal-incontinence-ix
    March 15, 2021 - Moreover, other bulking agents have not been studied to this degree or achieved approval by FDA for this
  13. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/environmental-monitoring-in-healthcare-to-ensure-adequacy-of-housekeeping-cleaning-and-reduce-the-spread-of-hospital-acquired-infections-hais
    December 03, 2013 - UV marker, ATP, viable count) used affects the possible HAI rate reductions that can be achieved (i.e … what the appropriate benchmark is for environmental surfaces that indicates adequate cleaning has been achieved
  14. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/update-treatments-fecal-incontinence-ii
    March 15, 2021 - Moreover, other bulking agents have not been studied to this degree or achieved approval by FDA for this
  15. effectivehealthcare.ahrq.gov/get-involved/nominated-topics/supplemental-oxygen-prescription-practices
    February 02, 2021 - technological advances leads to only one way to assure adequate prescribed oxygenation targets are achieved
  16. effectivehealthcare.ahrq.gov/products/depression-chronic-conditions-interventions/research
    August 13, 2012 - Our meta-analyses found that intervention recipients achieved greater improvement than controls in depression
  17. effectivehealthcare.ahrq.gov/products/hepatitis-c-treatment-adherence/research
    December 20, 2012 - studies reporting adherence showed statistically significant improvement in adherence, and two others achieved
  18. effectivehealthcare.ahrq.gov/products/phenylketonuria/research
    February 22, 2012 - effect of placebo on likelihood of a 30-percent reduction in Phe, only 9 percent of those on placebo achieved
  19. effectivehealthcare.ahrq.gov/sites/default/files/infectious-disease-horizon-scan-high-impact-1512.pdf
    January 28, 2016 - In a phase III study, patients with HCV genotype 1 infection achieved an average SVR12 rate of 92%. … In the phase III ION studies, patients achieved SVR12 rates of 94% to 99%. … Patients infected with HCV genotype 2 or 3 achieved SVR12 of 93% and 85%, respectively. … Overall, 99% of patients achieved SVR12; patients infected with HCV genotype 5 had the lowest SVR12 … In patients treated for 12 weeks, 92% achieved SVR12; in patients treated for 24 weeks, 96% achieved
  20. effectivehealthcare.ahrq.gov/products/asthma-treatment/research
    September 10, 2012 - Hyperventilation reduction interventions (particularly those with 5 hours or more of patient contact) achieved

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: